By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Contact Information

Website: www.chimerix.com
Email: ir@chimerix.com
Main Phone: +1 919 806-1074
Address: 2505 Meridian Parkway
Address 2: Suite 100
State: NC
City / Town: Durham
Country: US
Postal Code: 27713

Issuer Information

Exchange: NSD
CEO: Michael Sherman
Employees: 54
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A